Sai Geetika Agri Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.27 Cr
as on 28-12-2024
- Paid Up Capital ₹ 1.27 Cr
as on 28-12-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 28-12-2024
- Satisfied Charges ₹ 2.00 Cr
as on 28-12-2024
- Revenue 203.72%
(FY 2016)
- Profit 19.43%
(FY 2016)
- Ebitda 139.33%
(FY 2016)
- Net Worth 43.48%
(FY 2016)
- Total Assets 51.39%
(FY 2016)
About Sai Geetika Agri Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.27 Cr and a paid-up capital of Rs 1.27 Cr.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Swarna Vijayaramireddy and Swarna Vijayalakshmi serve as directors at the Company.
- CIN/LLPIN
U01119TG2010PTC070228
- Company No.
070228
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sai Geetika Agri Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swarna Vijayaramireddy  | Additional Director | 05-Feb-2015 | Current |
| Swarna Vijayalakshmi | Director | 30-Aug-2010 | Current |
Financial Performance of Sai Geetika Agri Biotech.
Sai Geetika Agri Biotech Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 203.72% increase. The company also saw a substantial improvement in profitability, with a 19.43% increase in profit. The company's net worth Soared by an impressive increase of 43.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Geetika Agri Biotech?
In 2017, Sai Geetika Agri Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 May 2015 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 11 May 2015 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Apr 2015 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Sai Geetika Agri Biotech?
Unlock and access historical data on people associated with Sai Geetika Agri Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Geetika Agri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Geetika Agri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
